Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 7.8B | 4.0B | 3.3B | 3.2B |
Cost of revenue | 1.2B | 937M | 823M | 783M |
Gross profit | 6.6B | 3.0B | 2.5B | 2.4B |
Operating expense | ||||
Research & development | 707M | 716M | 704M | 725M |
Selling general and admin | 2.0B | 1.6B | 1.4B | 1.5B |
Other operating expenses | — | — | — | — |
Operating income | 3.7B | 597M | 284M | 96M |
Non operating interest income | ||||
Income | 39M | 34M | 42M | 59M |
Expense | 68M | 60M | 60M | 60M |
Other income expense | -8M | — | -53M | -235M |
Pretax income | 3.7B | 571M | 213M | -140M |
Tax provision | 864M | 100M | 16M | -120M |
Net income | 2.8B | 471M | 197M | -20M |
Basic EPS | 10.1 | 1.7 | 0.7 | -0.1 |
Diluted EPS | 10.0 | 1.7 | 0.7 | -0.1 |
Basic average shares | 280M | 280M | 280M | 280M |
Diluted average shares | 282M | 283M | 283M | 280M |
EBITDA | 4.0B | 835M | 525M | 128M |
Net income from continuing op. | 2.8B | 471M | 197M | -20M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |